Related Experiment Video
Updated: May 5, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Impact of Intracranial Hemorrhage After Endovascular Treatment for Medium Vessel Occlusion
Satoru Fujiwara1, Kazutaka Uchida2, Tsuyoshi Ohta3
1Department of Neurology, Kobe City Medical Center General Hospital, Kobe , Japan.
Background And Objectives:
Endovascular treatment (EVT) for medium vessel occlusion (MeVO) raises concern about hemorrhagic complications; however, its clinical impact has not been elucidated. Therefore, we investigated the association between intracranial hemorrhage (ICH) after EVT for MeVO and functional outcomes.
Methods:
We conducted a post hoc analysis of the Japan Registry of NeuroEndovascular Therapy 4, a nationwide registry in Japan from 2015 to 2019 including 13 479 patients who underwent EVT for acute ischemic stroke. This study included 2465 patients with MeVO from 166 participating centers in Japan. We compared patients who underwent EVT for MeVO according to their hemorrhagic complication after EVT (no ICH, asymptomatic ICH, and symptomatic ICH). Outcomes included a modified Rankin scale (mRS) score at 30 days and all-cause mortality within 30 days. We estimated the odds ratios (ORs) and their CIs using a multivariable logistic regression model.
Results:
Among 2394 patients analyzed, 302 (12.6%) developed ICH, with 95 (31.5%) being symptomatic. Compared with the no-ICH group (n = 2092), the asymptomatic and symptomatic ICH groups had a lower proportion of patients with an mRS score of 0 to 2 at 30 days (41% vs 34%, vs 7.4%, P for trend <.001), with an adjusted ORs of 0.77 (95% CI, 0.53-1.12) and 0.12 (95% CI, 0.05-0.30) in the asymptomatic and symptomatic ICH groups, respectively. The adjusted common ORs of one-point shift of mRS score at 30 days in the asymptomatic ICH group was 0.76 (95% CI, 0.57-0.99) and that of the symptomatic ICH group was 0.13 (0.07-0.23), compared with the no-ICH group.
Conclusion:
ICH after EVT for MeVO was associated with worse outcomes, whether they were symptomatic or not. The optimal treatment devices or techniques to reduce ICH after EVT for MeVO are crucial.
Insights
Intracranial hemorrhage (ICH) after endovascular treatment (EVT) for medium vessel occlusion (MeVO) is linked to poorer functional outcomes. Minimizing ICH during EVT for MeVO is essential for improving patient results.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Stroke Medicine
Background:
- Endovascular treatment (EVT) is used for acute ischemic stroke due to medium vessel occlusion (MeVO).
- Hemorrhagic complications, specifically intracranial hemorrhage (ICH), are a concern following EVT for MeVO.
- The clinical impact of ICH on functional outcomes after EVT for MeVO requires elucidation.
Purpose of the Study:
- To investigate the association between intracranial hemorrhage (ICH) after EVT for MeVO and functional outcomes.
- To compare functional outcomes based on the presence and severity of ICH post-EVT for MeVO.
Main Methods:
- A post hoc analysis of the Japan Registry of NeuroEndovascular Therapy 4 (JRNT4) was performed.
- Included 2465 patients with MeVO who underwent EVT for acute ischemic stroke between 2015 and 2019.
- Patients were categorized by ICH occurrence (none, asymptomatic, symptomatic) and functional outcomes (mRS, mortality) were assessed.
Main Results:
- 12.6% of analyzed patients developed ICH, with 31.5% of those being symptomatic.
- Both asymptomatic and symptomatic ICH were associated with a lower likelihood of favorable functional outcomes (mRS 0-2 at 30 days).
- Adjusted odds ratios indicated significantly worse outcomes with symptomatic ICH (aOR 0.12) and a trend towards worse outcomes with asymptomatic ICH (aOR 0.77).
Conclusions:
- Intracranial hemorrhage following EVT for MeVO is associated with worse functional outcomes, regardless of symptom presentation.
- Developing optimal devices and techniques to minimize ICH during EVT for MeVO is critical.
- Further research into reducing hemorrhagic complications is warranted to improve stroke treatment efficacy.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

